BridgeBio Pharma (BBIO) Inventory (2025 - 2026)
BridgeBio Pharma (BBIO) posted Inventory of $33.0 million for Q1 2026, up 23.28% sequentially from $26.8 million in Q4 2025, and up 734.09% YoY from $4.0 million in Q1 2025.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Inventory (2025 - 2026) Analysis & Trends
BridgeBio Pharma has reported Inventory for 2 years, with the latest figure at $33.0 million in Q1 2026.
- Quarterly Inventory rose 734.09% year-over-year to $33.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.0 million (up 734.09% YoY) and the FY2025 annual result came in at $26.8 million, changed N/A from the prior year.
- Inventory rose to $33.0 million in Q1 2026 per BBIO's latest filing, from $26.8 million in the prior quarter.
- Over five years, Inventory peaked at $33.0 million in Q1 2026 and troughed at $4.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | BridgeBio Pharma | 14.65 Bn | 13.93 Bn | 228.63 Mn | 52.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 52.84 Mn |
| Mar 31, 2026 | 32.98 Mn |
| Dec 31, 2025 | 26.75 Mn |
| Sep 30, 2025 | 24.53 Mn |
| Jun 30, 2025 | 18.28 Mn |
| Mar 31, 2025 | 3.95 Mn |